AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

GlobeImmune, Inc.

$0 +$0.00 (+0.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0$0
Year Range
$0$0.04
Market Cap
575
AVG Volume
532
Trailing/Forward PE
-0/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD)
010M20M30M201320142015
GBIM Revenue (USD) by year
PeriodRevenue (USD)
20156.46M
20145.97M
201322.52M
Net Income (USD)
-20M-10M010M201320142015
GBIM Net Income (USD) by year
PeriodNet Income (USD)
2015-2.77M
2014-16.26M
20139.48M
Operating Income (USD)
-10M-5M05M10M201320142015
GBIM Operating Income (USD) by year
PeriodOperating Income (USD)
2015-2.77M
2014-5.82M
20137.69M
EBITDA (USD)
-20M-10M010M20M201320142015
GBIM EBITDA (USD) by year
PeriodEBITDA (USD)
2015-2.58M
2014-12.08M
201311.3M
Cash Flows (USD)
-15M-10M-5M05M201320142015
GBIM Cash Flows (USD) by year
PeriodCash Flows (USD)
2015-7.17M
2014-10.35M
20133.92M
EPS (USD)
-100102030201320142015
GBIM EPS (USD) by year
PeriodEPS (USD)
2015-0.51
2014-2.91
201329.61
Expenses (USD)
05M10M15MR&DSG&ACapex201320142015
GBIM Expenses (USD) by year
PeriodExpenses (USD)
20159.07M
201411.78M
201314.07M
Cash & Debt (USD)
05M10M15M20MCashLong Term Debt201320142015
GBIM Cash & Debt (USD) by year
PeriodCash & Debt (USD)
20159.9M
201416.81M
20135.92M
Debt ratios
01234201320142015
GBIM Debt ratios by year
PeriodDebt ratios
20152.34
20143.25
20130.92
Margins
0%20%40%60%80%201320142015
GBIM Margins by year
PeriodMargins
201558.99%
201416.33%
201373.47%
Return on Capital
-300%-200%-100%0%201320142015
GBIM Return on Capital by year
PeriodReturn on Capital
2015-92.59%
2014-290.19%
2013-4.75%
Shares Outstanding
02M4M6M201320142015
GBIM Shares Outstanding by year
PeriodShares Outstanding
20155.75M
20145.75M
201398.07K
Book Value Per Share (USD)
-3000-2000-100001000201320142015
GBIM Book Value Per Share (USD) by year
PeriodBook Value Per Share (USD)
20150.52
20140.97
2013-2032.51
Total Assets (USD)
05M10M15M20M201320142015
GBIM Total Assets (USD) by year
PeriodTotal Assets (USD)
201511.51M
201418.37M
20137.42M
Employee Count
010203020142015
GBIM Employee Count by year
PeriodEmployee Count
20152
201422
PE Ratio
0102030med 12.64Jul 14Aug 14Sep 14Oct 14Oct 14Nov 14Dec 14
GBIM PE Ratio by year
PeriodPE Ratio
Dec 1422.14
Dec 1420.58
Dec 1422.83
Dec 1420.67
Nov 1420.21
Nov 1421.52
Nov 1419.44
Nov 1419.62
Oct 1417.37
Oct 1415.76
Oct 1418.88
Oct 1426.25
Oct 1429.8
Sep 145.29
Sep 145.61
Sep 146.76
Sep 146.41
Aug 146.83
Aug 146.05
Aug 145.41
Aug 146.46
Aug 145.4
Jul 146.83
Jul 147.95
Jul 149.51
Jul 147.62
Free Cash Flow Yield
-150000000%-100000000%-50000000%0%med -1028709.56%Jan 25May 25Sep 25Jan 26May 26Sep 26
GBIM Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 26-1028709.53%
Sep 26-1028709.56%
Aug 26-1028709.56%
Aug 26-1028709.56%
Aug 26-1028709.56%
Aug 26-1028709.56%
Jul 26-1028709.56%
Jul 26-1028709.56%
Jul 26-1028709.56%
Jul 26-1028709.56%
Jul 26-1028709.56%
Jun 26-1028709.56%
Jun 26-1028709.56%
Jun 26-1028709.56%
Jun 26-1028709.56%
May 26-1028709.56%
May 26-1028709.56%
May 26-1028709.56%
May 26-1028709.56%
May 26-1028709.56%
Apr 26-1028709.56%
Apr 26-1028709.56%
Apr 26-1028709.56%
Apr 26-1028709.56%
Mar 26-1028709.56%
Mar 26-1028709.56%
Mar 26-1028709.56%
Mar 26-1028709.56%
Feb 26-1028709.56%
Feb 26-1028709.56%
Feb 26-102870953.24%
Feb 26-1028709.56%
Jan 26-1028709.56%
Jan 26-1028709.56%
Jan 26-1028709.56%
Jan 26-1028709.56%
Jan 26-1028709.53%
Dec 25-1028709.56%
Dec 25-1028709.56%
Dec 25-1028709.56%
Dec 25-1028709.56%
Nov 25-1028709.53%
Nov 25-1028709.56%
Nov 25-1028709.53%
Nov 25-1028709.56%
Oct 25-1028709.56%
Oct 25-1028709.56%
Oct 25-1028709.56%
Oct 25-1028709.56%
Oct 25-1028709.56%
Sep 25-1028709.56%
Sep 25-1028709.56%
Sep 25-1028709.56%
Sep 25-1028709.53%
Aug 25-1028709.56%
Aug 25-1028709.56%
Aug 25-1028709.56%
Aug 25-1028709.56%
Aug 25-1028709.56%
Jul 25-1028709.56%
Jul 25-1028709.56%
Jul 25-1028709.56%
Jul 25-1028709.56%
Jun 25-1028709.56%
Jun 25-514354.78%
Jun 25-514354.78%
Jun 25-514354.78%
May 25-514354.78%
May 25-514354.78%
May 25-514354.78%
May 25-514354.78%
May 25-514354.78%
Apr 25-514354.78%
Apr 25-514354.78%
Apr 25-514354.78%
Apr 25-514354.78%
Mar 25-514354.78%
Mar 25-514354.78%
Mar 25-514354.78%
Mar 25-514354.78%
Feb 25-514354.77%
Feb 25-514354.78%
Feb 25-514354.78%
Feb 25-514354.78%
Jan 25-514354.78%
Jan 25-514354.78%
Jan 25-514354.78%
Jan 25-102870953.24%
Jan 25-514354.78%
Dec 24-514354.78%
Dec 24-514354.78%
Dec 24-514354.78%
Dec 24-514354.78%
Nov 24-514354.78%
Nov 24-514354.78%
Nov 24-514354.78%
Nov 24-514354.78%
Nov 24-514354.78%
Oct 24-514354.78%
Oct 24-514354.78%
Price to Sales
00000med 0Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
GBIM Price to Sales by year
PeriodPrice to Sales
Sep 260
Sep 260
Aug 260
Aug 260
Aug 260
Aug 260
Jul 260
Jul 260
Jul 260
Jul 260
Jul 260
Jun 260
Jun 260
Jun 260
Jun 260
May 260
May 260
May 260
May 260
May 260
Apr 260
Apr 260
Apr 260
Apr 260
Mar 260
Mar 260
Mar 260
Mar 260
Feb 260
Feb 260
Feb 260
Feb 260
Jan 260
Jan 260
Jan 260
Jan 260
Jan 260
Dec 250
Dec 250
Dec 250
Dec 250
Nov 250
Nov 250
Nov 250
Nov 250
Oct 250
Oct 250
Oct 250
Oct 250
Oct 250
Sep 250
Sep 250
Sep 250
Sep 250
Aug 250
Aug 250
Aug 250
Aug 250
Aug 250
Jul 250
Jul 250
Jul 250
Jul 250
Jun 250
Jun 250
Jun 250
Jun 250
May 250
May 250
May 250
May 250
May 250
Apr 250
Apr 250
Apr 250
Apr 250
Mar 250
Mar 250
Mar 250
Mar 250
Feb 250
Feb 250
Feb 250
Feb 250
Jan 250
Jan 250
Jan 250
Jan 250
Jan 250
Dec 240
Dec 240
Dec 240
Dec 240
Nov 240
Nov 240
Nov 240
Nov 240
Nov 240
Oct 240
Oct 240
EV/EBITDA
0100200300med 6.14Jul 14Aug 14Oct 14Nov 14Jan 15Feb 15Mar 15
GBIM EV/EBITDA by year
PeriodEV/EBITDA
Mar 15265.89
Mar 15267.2
Mar 15244.84
Mar 15246.81
Feb 15276.41
Feb 15279.7
Feb 15295.49
Feb 15224.44
Jan 15217.21
Jan 15222.47
Jan 15207.34
Jan 15294.17
Jan 15281.68
Dec 146.6
Dec 146.11
Dec 146.82
Dec 146.14
Nov 145.99
Nov 146.4
Nov 145.75
Nov 145.81
Oct 145.1
Oct 144.6
Oct 145.58
Oct 147.89
Oct 149
Sep 143.73
Sep 144
Sep 144.95
Sep 144.66
Aug 145.01
Aug 144.37
Aug 143.83
Aug 144.7
Aug 143.83
Jul 145.01
Jul 145.93
Jul 147.22
Jul 145.66
Price/Operating Cashflow
2025303540med 25.3Jul 14Jul 14Aug 14Aug 14Aug 14Sep 14Sep 14
GBIM Price/Operating Cashflow by year
PeriodPrice/Operating Cashflow
Sep 1420.71
Sep 1422
Sep 1426.48
Sep 1425.12
Aug 1426.76
Aug 1423.72
Aug 1421.19
Aug 1425.3
Aug 1421.17
Jul 1426.79
Jul 1431.15
Jul 1437.27
Jul 1429.86
Price to Book
0000med 0Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
GBIM Price to Book by year
PeriodPrice to Book
Sep 260
Sep 260
Aug 260
Aug 260
Aug 260
Aug 260
Jul 260
Jul 260
Jul 260
Jul 260
Jul 260
Jun 260
Jun 260
Jun 260
Jun 260
May 260
May 260
May 260
May 260
May 260
Apr 260
Apr 260
Apr 260
Apr 260
Mar 260
Mar 260
Mar 260
Mar 260
Feb 260
Feb 260
Feb 260
Feb 260
Jan 260
Jan 260
Jan 260
Jan 260
Jan 260
Dec 250
Dec 250
Dec 250
Dec 250
Nov 250
Nov 250
Nov 250
Nov 250
Oct 250
Oct 250
Oct 250
Oct 250
Oct 250
Sep 250
Sep 250
Sep 250
Sep 250
Aug 250
Aug 250
Aug 250
Aug 250
Aug 250
Jul 250
Jul 250
Jul 250
Jul 250
Jun 250
Jun 250
Jun 250
Jun 250
May 250
May 250
May 250
May 250
May 250
Apr 250
Apr 250
Apr 250
Apr 250
Mar 250
Mar 250
Mar 250
Mar 250
Feb 250
Feb 250
Feb 250
Feb 250
Jan 250
Jan 250
Jan 250
Jan 250
Jan 250
Dec 240
Dec 240
Dec 240
Dec 240
Nov 240
Nov 240
Nov 240
Nov 240
Nov 240
Oct 240
Oct 240
GlobeImmune, Inc.
GBIM
Stockpicker

Video analysis: GBIM

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.